Re:

I have been trying to hook up with Kevin and will see him tomorrow. I still
prefer to use the "old exec committee plus" for this PRC with a reformed MD
PRC starting at mid year. We have too many people in transition to just
switch over to the policy committee at this stage.

Cindy Olson
12/04/2000 09:10 AM

To: Steven J Kean/NA/Enron@Enron
cc:
Subject: Re:

Steve, my preference is the first option however I can live with either
really.......we just need to make a decision ......what do you think??????
---------------------- Forwarded by Cindy Olson/Corp/Enron on 12/04/2000
09:00 AM ---------------------------

David Oxley@ECT
12/04/2000 08:29 AM
To: Cindy Olson/Corp/Enron@ENRON
cc: Gina Corteselli/Corp/Enron@Enron, Andrea Yowman/Corp/Enron@ENRON

Subject: Re:

How can we resolve today if possible?
---------------------- Forwarded by David Oxley/HOU/ECT on 12/04/2000 08:28
AM ---------------------------

Kevin Hannon@ENRON COMMUNICATIONS on 12/02/2000 10:12:58 AM
To: Gina Corteselli/Corp/Enron@ENRON
cc: Cindy Olson/Corp/Enron@ENRON, David Oxley/HOU/ECT@ECT@ENRON, Steven J
Kean/NA/Enron@Enron
Subject: Re:

You know my opinion, I vote for option #2.

Kevin

Gina Corteselli@ENRON
11/30/00 07:19 PM

To: Steven J Kean/NA/Enron@Enron, Kevin Hannon/Enron Communications@Enron
Communications, Cindy Olson/Corp/Enron@ENRON
cc: David Oxley/HOU/ECT@ECT
Subject:

Following discussions with Steve and Kevin yesterday, we're providing some
options for the conduct of final PRC reviews for the Enron VP's and MD's.
Please let us know which of these options (or a derivative therein) you'd
prefer.

For continuity through the year-end process, we might consider having the
existing MD VP PRC Committee review the VP slate; and the former EC and two
newly appointed EC members who are also VP PRC Committee, (John Lavorato
and Jeff Shankman were suggested), ratify the VP slate and review the
MD's. The newly appointed EC members who are MD level will remain in the
"Not Rated" category, so that Jeff and John may participate in the overall
discussion and depart before discussions relative to them and their EC
colleagues.

Alternatively, we might disband the existing MD VP PRC Committee in favor of
having the newly appointed EC (13 of whom are MD VP PRC) review the VP
slate. Thereafter, the Enron Corporate Policy Committee would be responsible
for ratifying these results and for reviewing the MD's slate. Insofar as the
Policy Committee might require further information on individual MD's,
selected EC members could be invited for an appropriate period of time to
provide the necessary details.

If we opt to disband the existing MD VP PRC we'd need to notify those members
who aren't part of the new EC that their services are no longer required. In
so much as some of these people are currently assigned to, and attending, BU
and functional pre-rankings clearly the sooner we are able to do this, the
better.

Your immediate attention to this issue would be greatly appreciated, since we
are eager to begin the year-end VP/MD PRC planning process. Thanks in
advance,

Gina Corteselli